Previous studies from our laboratory have demonstrated that both chronic inflammatory pain, induced by intraplantar injection of complete Freund's adjuvant (CFA), and prolonged (48 h) stimulation of mu-opioid receptors (mOR) by systemic administration of a variety of selective agonists, resulted in enhanced plasma membrane targeting of delta-opioid receptors (dOR) in neurons of the dorsal spinal cord. To determine whether dOR trafficking induced by chronic inflammation was dependent on the activation of mOR, we investigated by immunogold cytochemistry the effects of intraplantar CFA injection on the plasma membrane density of dOR in mOR knockout (KO) mice. In untreated wild-type (WT) mice, only a small proportion of dOR was associated with neuronal plasma membranes in the dorsal horn of the spinal cord. The CFA-induced inflammation produced a significantly higher ratio of plasma membrane to intracellular receptors, as well as a 75% increase in the membrane density of immunoreactive dOR, in dendrites of the ipsilateral dorsal horn as compared to untreated mice. This increase in the membrane density of dOR was likely due to a recruitment of receptors from intracellular stores since no difference in the overall dOR immunolabeling density was evident between CFA-treated and untreated mice. Most importantly, the CFA-induced changes in dOR plasma membrane insertion seen in WT animals were not present in the spinal cord of mOR KO mice. These results demonstrate that the integrity of mOR is necessary for CFA-induced changes in dOR trafficking to occur and suggest that these changes could be elicited by stimulation of mOR by endogenous opioids released in response to chronic inflammatory pain. q
Introduction
Administration of opioid analgesics directly into the central nervous system (CNS) produces a profound increase in nociceptive thresholds in various animal models of acute and chronic pain. For example, in models of chronic inflammatory pain, spinal administration of mu-(m) or delta-(d) opioid receptor (OR) agonists have been shown to reverse thermal hyperalgesia precipitated in these models (Cahill et al., 2003; Ossipov et al., 1995; Qiu et al., 2000; Stewart and Hammond, 1994) . Moreover, dOR-induced anti-nociceptive effects were shifted to the left compared to controls, indicating an augmentation in analgesic potency, following induction of inflammation via carrageenan (Stewart and Hammond, 1994) or complete Freund's adjuvant (CFA) injection (Cahill et al., 2003; Fraser et al., 2000; Hylden et al., 1991; Qiu et al., 2000) . Nonetheless, the mechanisms by which centrally administered opioids alleviate persistent inflammatory pain states are not well understood.
Plastic changes have been documented to occur in the spinal cord in response to persistent inflammatory pain (Julius and Basbaum, 2001 ). Some of these changes affect the expression and subcellular distribution of dOR in neurons of the dorsal horn of the spinal cord and dorsal root ganglia (Besse et al., 1992; Cahill et al., 2003; Ji et al., 1995) . Under basal conditions, dOR are almost exclusively localized to intracellular compartments in neurons throughout the CNS, 
